🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07695025
Starting soon Not applicable

Injection Site in Ultrasound-Guided Interscalene Block for Shoulder Arthroscopy

NCT07695025 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-07-15
Last updated
2026-07-10

Condition(s) studied

Shoulder ArthroscopyPostoperative Pain

Investigational drug(s) / intervention(s)

Ultrasound-Guided Interscalene Block

Ultrasound-Guided Interscalene Block: Ultrasound-guided interscalene brachial plexus block performed before induction of general anesthesia. Participants are assigned to one of two injection sites around the C5-C7 nerve roots according to the randomized study protocol.

Study summary

Ultrasound-guided interscalene block is commonly used for postoperative analgesia in patients undergoing shoulder arthroscopy. The location of local anesthetic injection may influence both block efficacy and the incidence of block-related complications. This randomized, double-blind clinical trial compares two different injection sites around the C5-C7 nerve roots using the same local anesthetic dose and volume. The study will assess block success, postoperative analgesia, opioid consumption, diaphragmatic function, and procedure-related complications.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: Adults aged 18 years or older. ASA physical status I-III. Scheduled for shoulder arthroscopy under general anesthesia with a planned ultrasound-guided interscalene block for postoperative analgesia. Able to provide written informed consent. Normal coagulation parameters and no antithrombotic therapy. No infection or anatomical abnormality at the injection site. No known allergy to local anesthetics. No contralateral diaphragmatic paralysis or pneumothorax. No dyspnea and adequate pulmonary function. Exclusion Criteria: Age younger than 18 years or ASA physical status IV. Antithrombotic therapy or abnormal coagulation parameters. Infection or anatomical abnormality at the injection site. Known allergy to local anesthetics. Contralateral diaphragmatic paralysis or history of pneumothorax. Dyspnea. Refusal to undergo interscalene block.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Sultan Abdulhamid Han Training and Research Hospital Istanbul Istanbul

More Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07695025 on ClinicalTrials.gov ↗ ← All trials in Turkey